Yorulmaz, G. Et Al. 2022. Intestinal microbiota composition inpatients with type 2 diabetes and effects of 12 weeks of oral anti-diabetic treatment. ENDO 2022 , (Georgia, United States Of America), 1-4.

Yorulmaz, G., Akalın, A., Kalkan, A. T., Kaya, M., Varis, A., & Dinleyici, E. Ç., (2022). Intestinal microbiota composition inpatients with type 2 diabetes and effects of 12 weeks of oral anti-diabetic treatment . ENDO 2022 (pp.1-4). Georgia, United States Of America

Yorulmaz, GÖKNUR Et Al. "Intestinal microbiota composition inpatients with type 2 diabetes and effects of 12 weeks of oral anti-diabetic treatment," ENDO 2022, Georgia, United States Of America, 2022

Yorulmaz, GÖKNUR Et Al. "Intestinal microbiota composition inpatients with type 2 diabetes and effects of 12 weeks of oral anti-diabetic treatment." ENDO 2022 , Georgia, United States Of America, pp.1-4, 2022

Yorulmaz, G. Et Al. (2022) . "Intestinal microbiota composition inpatients with type 2 diabetes and effects of 12 weeks of oral anti-diabetic treatment." ENDO 2022 , Georgia, United States Of America, pp.1-4.

@conferencepaper{conferencepaper, author={GÖKNUR YORULMAZ Et Al. }, title={Intestinal microbiota composition inpatients with type 2 diabetes and effects of 12 weeks of oral anti-diabetic treatment}, congress name={ENDO 2022}, city={Georgia}, country={United States Of America}, year={2022}, pages={1-4} }